Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine

By Trivello R.   Chiaramonte M.   Ngatchu T.   Baldo V.   Majori S.   Moschen M.E.   Simoncello I.   Renzulli G.   Naccarato R.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 139-141

Elsevier

Access to resources Recommend Favorite

Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence

By Gesemann M.   Scheiermann N.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 443-447

Elsevier

Access to resources Recommend Favorite

Analysis of anti-HBs levels in healthcare workers over 10 years following booster vaccination for hepatitis B virus

By Nakao K.   Hamasaki K.   Wakihama N.   Maeda M.   Ohtsubo N.   Sagiike T.   Ichikawa T.   Ishikawa H.   Eguchi K.   Ishii N.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3789-3794

Elsevier

Access to resources Recommend Favorite

Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results

By Van Herck K.   Van Damme P.   Thoelen S.   Meheus A.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1933-1935

Elsevier

Access to resources Recommend Favorite

Low-dose intradermal administration of recombinant hepatitis B vaccine in children: 5-year follow-up study

By Kurugol Z.   Erensoy S.   Aksit S.   Egemen A.   Bilgic A.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3936-3939

Elsevier

Access to resources Recommend Favorite